Home » Pharma News (page 3)

Pharma News

Benefits of daily aspirin outweigh risk to stomach

Benefits of daily aspirin outweigh risk to stomach Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University. Published in the journal Public Library of Science, the extensive study of literature on aspirin reveals that while regular use of the drug ... Read More »

Pharma Patients stocking daily-use medicines; deferring optional surgeries

Patients stocking daily-use medicines; deferring optional surgeries Demonetisation has had another side effect – patients are stocking up medicines for the next two to three months. This is especially so for ailments where life-long mediations are required such as for diabetes or hypertension – called chronic therapy areas in medical lingo. As a result, some of the pharmacies have seen ... Read More »

Cipla divests 16.7 per cent stake in Chase Pharma to Allergan

Cipla divests 16.7 per cent stake in Chase Pharma to Allergan Drug major CiplaBSE 0.45 % today said Chase Pharmaceuticals Corporation, in which it has 16.7 per cent stake has been acquired by Ireland-headquartered Allergan plc. Delaware-based Chase Pharmaceuticals Corporation, in which the company’s UK arm Cipla (EU) Ltd has 16.7 per cent stake, has been acquired by a subsidiary ... Read More »

Zydus Cadila gets USFDA nod for anti-infections tablets

Zydus Cadila gets USFDA nod for anti-infections tablets NEW DELHI: Drug firm Zydus Cadila has received final approval from the US health regulator to market its Metronidazole tablets used for the treatment of infections caused by bacteria or parasites. The company has received “final approval from the United States Food and Drug Administration (USFDA) to market Metronidazole tablets USP in ... Read More »

Pharma city to be connected with MMT

 Pharma city to be connected with MMTS Hyderabad: Industries and municipal administration minister KT Rama Rao said the upcoming Pharma City on the outskirts of the city will be connected with a multi-modal transit system apart from linking Outer Ring Road, the proposed Regional Ring Road and National and state highways. These would be incorporated in the master plan for ... Read More »

For skull surgery Chinese doctors use 3D printer

For skull surgery Chinese doctors use 3D printer  BEIJING: Chinese doctors have successfully replaced a section of a woman cancer patient’s forehead with a 3D-printed part. The patient who is in her early 20s had recurrent tumours for over 16 years and had kept her hair long at the front to cover the growths. “I have had bangs for over ... Read More »

GSK presents new data backing shingles vaccine

GSK presents new data backing shingles vaccine The firm says data show that when Shingrix was given to patients aged 50 years or over at the same time as an unadjuvanted seasonal flu vaccine, both vaccines were well tolerated and the immune response to each vaccine was similar whether it was administered at the same time or separately. On the ... Read More »

Bristol Opdivo discount in kidney cancer changes minds at NICE

Bristol Opdivo discount in kidney cancer changes minds at NICE In July, England’s cost watchdogs weren’t keen on covering Bristol-Myers Squibb’s Opdivo for kidney cancer patients. But the New Jersey drugmaker has said the magic word: discount. Friday, the National Institute for Health and Care Excellence announced a flip-flop on the idea, backing the med for NHS use in previously ... Read More »

Our Culture

Our Culture At VIVAN, our performance-oriented culture and responsible approach are the foundations of our success. We recognize that our business depends on the creativity, innovation, dedication and performance of our Associates. We encourage our Associates to focus on achievements through collaboration, innovation and team work. We support our Associates to take freedom with responsibility, which eventually guides them to ... Read More »

Pharma cos may report low key performance in Q2 FY17

Pharma cos may report low key performance in Q2 FY17   Domestic pharmaceutical companies are likely to report subdued sales, EBITDA and PAT figures in the second quarter of this fiscal, even as the formulations business may see a strong recovery, a report said. “We expect the pharmaceutical companies to report subdued performance on sales, EBITDA and PAT front in ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes